Vicapsys Life Sciences, Inc.
VICP
Revenue
0.00
0.000.00%
-Assets
39.66k
▼-168.83k▼-80.98%
3 Months ChangeLiabilities
1.97M
▲425.97k▲27.62%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-12-27
Form 8-K
ID: 0001493152-23-046217
2023-11-14
Form 10-Q
ID: 0001493152-23-040951
2023-08-14
Form 10-Q
ID: 0001493152-23-028151
2023-06-30
Form 8-K
ID: 0001493152-23-023183
2023-06-02
Form 8-K
ID: 0001493152-23-019905
2023-05-17
Form 8-K
ID: 0001493152-23-017970
2023-05-15
Form 10-Q
ID: 0001493152-23-017138
2023-01-12
Form 8-K
ID: 0001493152-23-001296
2022-11-21
Form 10-Q
ID: 0001493152-22-033024
2022-09-28
Form 8-K
ID: 0001493152-22-027017